MedPath

Natravox

Brand Name: Natravox

Generic Name: Co-Amoxiclav

Active
Registration Number

DR-XY34785

Dosage Form

Powder For Suspension

Issuance Date

January 31, 2023

Expiry Date

August 12, 2028

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength125mg/31.25mg per 5mL
PackagingAmber Glass Bottle x 60mL (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Antibacterial (Penicillin/Beta-Lactamase Inhibitor)
A
Application
Automatic Renewal
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Co-AmoxiclavActive
Monograph: co-amoxiclav

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform